Chargement en cours...

Prevalence and Clinical Impact of Heterogeneous Vancomycin-Intermediate Staphylococcus aureus Isolated From Hospitalized Patients

BACKGROUND: We estimated the prevalence and clinical impact of heterogeneous vancomycin-intermediate Staphylococcus aureus (hVISA). The concordance between macromethod and glycopeptide resistance detection (GRD) E tests was determined. In addition, predictors of clinical outcomes in hospitalized pat...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Ann Lab Med
Auteurs principaux: Koh, Young Rae, Kim, Kye-Hyung, Chang, Chulhun L., Yi, Jongyoun
Format: Artigo
Langue:Inglês
Publié: The Korean Society for Laboratory Medicine 2016
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4773264/
https://ncbi.nlm.nih.gov/pubmed/26915612
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3343/alm.2016.36.3.235
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!